Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.5 GBX | +1.14% | +2.30% | -17.59% |
05-08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
05-08 | The Brighton Pier Group PLC Reports Earnings Results for the Full Year Ended December 24, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 |
---|---|---|---|---|---|---|
Capitalization 1 | 27.03 | 19.39 | 11.37 | 24.05 | 21.11 | 16.59 |
Enterprise Value (EV) 1 | 40.9 | 31.45 | 11.37 | 37.15 | 21.11 | 23.29 |
P/E ratio | - | - | -1.2 x | 5.61 x | 3.34 x | 3.87 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.85 x | 0.61 x | - | 1.78 x | - | 0.47 x |
EV / Revenue | 1.29 x | 0.98 x | - | 2.74 x | - | 0.66 x |
EV / EBITDA | 7.9 x | 5.91 x | - | 7.28 x | 1.51 x | 4.23 x |
EV / FCF | - | - | - | 8.03 x | - | 29.1 x |
FCF Yield | - | - | - | 12.4% | - | 3.43% |
Price to Book | 1.22 x | - | - | - | - | 0.74 x |
Nbr of stocks (in thousands) | 37,286 | 37,286 | 37,286 | 37,286 | 37,356 | 37,286 |
Reference price 2 | 0.7250 | 0.5200 | 0.3050 | 0.6450 | 0.5650 | 0.4450 |
Announcement Date | 25/09/18 | 23/09/19 | 02/11/20 | 01/11/21 | 24/04/23 | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 |
---|---|---|---|---|---|---|
Net sales 1 | 31.68 | 32.02 | - | 13.54 | - | 35.1 |
EBITDA 1 | 5.175 | 5.326 | - | 5.101 | 13.93 | 5.5 |
EBIT 1 | 3.602 | 3.726 | - | 2.389 | 8.981 | 2.6 |
Operating Margin | 11.37% | 11.64% | - | 17.64% | - | 7.41% |
Earnings before Tax (EBT) 1 | 2.268 | - | - | 4.198 | 7.639 | 5.7 |
Net income 1 | 1.761 | - | -9.493 | 4.279 | 6.373 | 4.3 |
Net margin | 5.56% | - | - | 31.6% | - | 12.25% |
EPS 2 | - | - | -0.2550 | 0.1150 | 0.1690 | 0.1150 |
Free Cash Flow 1 | - | - | - | 4.624 | - | 0.8 |
FCF margin | - | - | - | 34.15% | - | 2.28% |
FCF Conversion (EBITDA) | - | - | - | 90.65% | - | 14.55% |
FCF Conversion (Net income) | - | - | - | 108.06% | - | 18.6% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 25/09/18 | 23/09/19 | 02/11/20 | 01/11/21 | 24/04/23 | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2020 S1 | 2022 S1 |
---|---|---|
Net sales 1 | 17.3 | 17.33 |
EBITDA | - | - |
EBIT | - | - |
Operating Margin | - | - |
Earnings before Tax (EBT) | - | - |
Net income | - | - |
Net margin | - | - |
EPS 2 | 0.0390 | 0.009000 |
Dividend per Share | - | - |
Announcement Date | 17/03/20 | 26/09/22 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 |
---|---|---|---|---|---|---|
Net Debt 1 | 13.9 | 12.1 | - | 13.1 | - | 6.7 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.681 x | 2.265 x | - | 2.568 x | - | 1.218 x |
Free Cash Flow 1 | - | - | - | 4.62 | - | 0.8 |
ROE (net income / shareholders' equity) | - | - | - | - | - | 3.1% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | 0.5900 | - | - | - | - | 0.6000 |
Cash Flow per Share | 0.0700 | 0.0900 | - | - | - | - |
Capex 1 | 3.34 | 2.55 | - | 0.26 | - | 0.9 |
Capex / Sales | 10.53% | 7.96% | - | 1.91% | - | 2.56% |
Announcement Date | 25/09/18 | 23/09/19 | 02/11/20 | 01/11/21 | 24/04/23 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.59% | 20.59M | |
-12.09% | 47.38B | |
+2.37% | 3.36B | |
+12.44% | 2.29B | |
+6.54% | 2.27B | |
+21.11% | 1.17B | |
-20.00% | 779M | |
+14.12% | 645M | |
+1.70% | 602M | |
+37.07% | 521M |
- Stock Market
- Equities
- PIER Stock
- Financials The Brighton Pier Group PLC